Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam / Daniel L. Wolf en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 51-57 Título : Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam Tipo de documento: texto impreso Autores: Daniel L. Wolf, Autor ; Paul J. Desjardins, Autor ; Peter M. Black, Autor Fecha de publicación: 2023 Artículo en la página: pp. 51-57 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alprazolam, Ansiolíticos, Ansiedad, Presión arterial. Resumen: Alprazolam, a benzodiazepine anxiolytic, was evaluated in anxious patients prior to oral surgery. This population represents a possible acute screening model for novel anxiolytic agents. Healthy subjects, preselected for a moderate to high degree of dental anxiety based upon Corah’s Dental Anxiety Scale, were enrolled in a three-arm parallel design study and randomly assigned to receive double-blind placebo (N=15), alprazolam 0.25 mg (N=16) or alprazolam 1 mg (N=16). Subjective selfreported anxiety was rated using the State Anxiety Inventory and visual analog scales. Link: ./index.php?lvl=notice_display&id=31045 [artículo] Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam [texto impreso] / Daniel L. Wolf, Autor ; Paul J. Desjardins, Autor ; Peter M. Black, Autor . - 2023 . - pp. 51-57. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 51-57 Palabras clave: Alprazolam, Ansiolíticos, Ansiedad, Presión arterial. Resumen: Alprazolam, a benzodiazepine anxiolytic, was evaluated in anxious patients prior to oral surgery. This population represents a possible acute screening model for novel anxiolytic agents. Healthy subjects, preselected for a moderate to high degree of dental anxiety based upon Corah’s Dental Anxiety Scale, were enrolled in a three-arm parallel design study and randomly assigned to receive double-blind placebo (N=15), alprazolam 0.25 mg (N=16) or alprazolam 1 mg (N=16). Subjective selfreported anxiety was rated using the State Anxiety Inventory and visual analog scales. Link: ./index.php?lvl=notice_display&id=31045

---

1 (1 - 1 / 1)